Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and α4β7 integrin expression by NK cells

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 7014-7025

  Bouchentouf, Manaf ^a   Forner, Kathy Ann ^a   Cuerquis, Jessica ^a   Michaud, Véronique ^a   Zheng, Jiamin ^a   Paradis, Pierre ^a   Schiffrin, Ernesto L ^a   Galipeau, Jacques ^a,b,c,d  

^a MCGILL UNIVERSITY   (Canada)

^b EMORY UNIVERSITY   (United States)

^c Medical Oncology ^*  (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CD161 ANTIGEN; INTEGRIN; INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE CELL ADHESION MOLECULE; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADOPTIVE TRANSFER; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROSIS; GENE SILENCING; HEART INFARCTION; HEART MUSCLE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LYMPHOID CELL; MALE; MONOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; INTEGRINS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650660392     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001888     Document Type: Article

References (59)

1. Hill, J. H., and P. A. Ward. 1971. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133:885-900.
2. Pinckard, R. N., M. S. Olson, P. C. Giclas, R. Terry, J. T. Boyer, and R. A. O'Rourke. 1975. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J. Clin. Invest. 56:740-750.
3. Rossen, R. D., L. H. Michael, H. K. Hawkins, K. Youker, W. J. Dreyer, R. E. Baughn, and M. L. Entman. 1994. Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ. Res. 75:546-555.
4. Lefer, D. J., and D. N. Granger. 2000. Oxidative stress and cardiac disease. Am. J. Med. 109:315-323.
5. Dhalla, N. S., A. B. Elmoselhi, T. Hata, and N. Makino. 2000. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc. Res. 47:446-456.
6. Frangogiannis, N. G., M. L. Lindsey, L. H. Michael, K. A. Youker, R. B. Bressler, L. H. Mendoza, R. N. Spengler, C. W. Smith, and M. L. Entman. 1998. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98:699-710.
7. Singh, M., and H. K. Saini. 2003. Resident cardiac mast cells and ischemiareperfusion injury. J. Cardiovasc. Pharmacol. Ther. 8:135-148.
8. Constantinides, P. 1995. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1083.
9. Frangogiannis, N. G., J. L. Perrard, L. H. Mendoza, A. R. Burns, M. L. Lindsey, C. M. Ballantyne, L. H. Michael, C. W. Smith, and M. L. Entman. 1998. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98:687-698.
10. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565-568.
11. Kukielka, G. L., C. W. Smith, G. J. LaRosa, A. M. Manning, L. H. Mendoza, T. J. Daly, B. J. Hughes, K. A. Youker, H. K. Hawkins, L. H. Michael, et al. 1995. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J. Clin. Invest. 95:89-103.
12. Birdsall, H. H., D. M. Green, J. Trial, K. A. Youker, A. R. Burns, C. R. MacKay, G. J. LaRosa, H. K. Hawkins, C. W. Smith, L. H. Michael, et al. 1997. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 95:684-692.
13. Weihrauch, D., R. Zimmermann, M. Arras, and J. Schaper. 1994. Expression of extracellular matrix proteins and the role of fibroblasts and macrophages in repair processes in ischemic porcine myocardium. Cell. Mol. Biol. Res. 40:105-116.
14. Trial, J., R. E. Baughn, J. N. Wygant, B. W. McIntyre, H. H. Birdsall, K. A. Youker, A. Evans, M. L. Entman, and R. D. Rossen. 1999. Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration. J. Clin. Invest. 104:419-430.
15. Yang, Z., B. Zingarelli, and C. Szabó. 2000. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 101:1019-1026.
16. Heeschen, C., S. Dimmeler, C. W. Hamm, S. Fichtlscherer, E. Boersma, M. L. Simoons, A. M. Zeiher; CAPTURE Study Investigators. 2003. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107:2109-2114.
17. Ayach, B. B., M. Yoshimitsu, F. Dawood, M. Sun, S. Arab, M. Chen, K. Higuchi, C. Siatskas, P. Lee, H. Lim, et al. 2006. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc. Natl. Acad. Sci. USA 103:2304-2309.
18. Bouchentouf, M., P. Paradis, K. Forner, J. Cuerquis, M. Boivin, Z. Jiamin, M. Boulassel, J. Routy, E. Schiffrin, and J. Galipeau. 2010. Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction. Cell Transplant 19:369-386.
19. Niclou, S. P., C. Danzeisen, H. P. Eikesdal, H. Wiig, N. H. Brons, A. M. Poli, A. Svendsen, A. Torsvik, P. O. Enger, J. A. Terzis, and R. Bjerkvig. 2008. A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. FASEB J. 22:3120-3128.
20. Lin, Y., Y. Zhong, S. Saito, Y. Chen, W. Shen, J. Di, and S. Zeng. 2009. Characterization of natural killer cells in nonobese diabetic/severely compromised immunodeficient mice during pregnancy. Fertil. Steril. 91:2676-2686.
21. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180-191.
22. Eckle, T., A. Grenz, D. Köhler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig. 2006. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291: H2533-H2540.
23. Metzler, B., A. Hammerer-Lercher, J. Jehle, H. Dietrich, O. Pachinger, Q. Xu, and J. Mair. 2002. Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin. Chim. Acta 325:87-90.
24. Aries, A., P. Paradis, C. Lefebvre, R. J. Schwartz, and M. Nemer. 2004. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc. Natl. Acad. Sci. USA 101:6975-6980.
25. Iglarz, M., R. M. Touyz, E. C. Viel, P. Paradis, F. Amiri, Q. N. Diep, and E. L. Schiffrin. 2003. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis inmineralocorticoid-dependent hypertension. Hypertension 42:737-743.
26. Riad, A., S. Jäger, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M. M. Heimesaat, S. Bereswill, D. Dragun, et al. 2008. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 180:6954-6961.
27. Aigner, F., H. T. Maier, H. G. Schwelberger, E. A. Wallnöfer, A. Amberger, P. Obrist, T. Berger, T. W. Mak, M. Maglione, R. Margreiter, et al. 2007. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am. J. Transplant. 7:779-788.
28. Frangogiannis, N. G. 2004. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm. Res. 53:585-595.
29. Ren, G., O. Dewald, and N. G. Frangogiannis. 2003. Inflammatory mechanisms in myocardial infarction. Curr. Drug Targets Inflamm. Allergy 2:242-256.
30. Naito, K., T. Anzai, Y. Sugano, Y. Maekawa, T. Kohno, T. Yoshikawa, K. Matsuno, and S. Ogawa. 2008. Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction. J. Immunol. 181:5691-5701.
31. Lindsey, M. L., J. Gannon, M. Aikawa, F. J. Schoen, E. Rabkin, L. Lopresti-Morrow, J. Crawford, S. Black, P. Libby, P. G. Mitchell, and R. T. Lee. 2002. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 105:753-758.
32. Goodchild, T. T., K. A. Robinson, W. Pang, F. Tondato, J. Cui, J. Arrington, L. Godwin, M. Ungs, N. Carlesso, N. Weich, et al. 2009. Bone marrow-derived B cells preserve ventricular function after acute myocardial infarction. JACC Cardiovasc. Interv. 2:1005-1016.
33. Blankesteijn, W. M., E. Creemers, E. Lutgens, J. P. Cleutjens, M. J. Daemen, and J. F. Smits. 2001. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol. Scand. 173:75-82.
34. Varda-Bloom, N., J. Leor, D. G. Ohad, Y. Hasin, M. Amar, R. Fixler, A. Battler, M. Eldar, and D. Hasin. 2000. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J. Mol. Cell. Cardiol. 32:2141-2149.
35. Ulrich, M. M., A. M. Janssen, M. J. Daemen, L. Rappaport, J. L. Samuel, F. Contard, J. F. Smits, and J. P. Cleutjens. 1997. Increased expression of fibronectin isoforms after myocardial infarction in rats. J. Mol. Cell. Cardiol. 29:2533-2543.
36. Battegay, E. J. 1995. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med. 73:333-346.
37. Mentzer, S. J., S. H. Gromkowski, A. M. Krensky, S. J. Burakoff, and E. Martz. 1985. LFA-1 membrane molecule in the regulation of homotypic adhesions of human B lymphocytes. J. Immunol. 135:9-11.
38. Dustin, M. L., and T. A. Springer. 1989. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619-624.
39. Postigo, A. A., P. Sánchez-Mateos, A. I. Lazarovits, F. Sánchez-Madrid, and M. O. de Landázuri. 1993. Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes. J. Immunol. 151:2471-2483.
40. Rüegg, C., A. A. Postigo, E. E. Sikorski, E. C. Butcher, R. Pytela, and D. J. Erle. 1992. Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J. Cell Biol. 117:179-189.
41. Pérez-Villar, J. J., J. M. Zapata, I. Melero, A. Postigo, E. Sánchez-Madrid, and M. López-Botet. 1996. Expression and function of alpha 4/beta 7 integrin on human natural killer cells. Immunology 89:96-104.
42. Vanderslice, P., C. L. Munsch, E. Rachal, D. Erichsen, K. M. Sughrue, A. N. Truong, J. N. Wygant, B. W. McIntyre, S. G. Eskin, R. G. Tilton, and P. J. Polverini. 1998. Angiogenesis induced by tumor necrosis factor-agr; is mediated by alpha4 integrins. Angiogenesis 2:265-275.
43. Mattila, P., M. L. Majuri, P. S. Mattila, and R. Renkonen. 1992. TNF alphainduced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation. Scand. J. Immunol. 36:159-165.
44. Li, Y., M. Hofmann, Q. Wang, L. Teng, L. K. Chlewicki, H. Pircher, and R. A. Mariuzza. 2009. Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. Immunity 31:35-46.
45. Lampugnani, M. G., and E. Dejana. 2007. The control of endothelial cell functions by adherens junctions. Novartis Found. Symp. 283:4-13; discussion 13-17, 238-241.
46. Hajra, K. M., and E. R. Fearon. 2002. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34:255-268.
47. Levenberg, S., A. Yarden, Z. Kam, and B. Geiger. 1999. p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry. Oncogene 18:869-876.
48. Uglow, E. B., S. Slater, G. B. Sala-Newby, C. M. Aguilera-Garcia, G. D. Angelini, A. C. Newby, and S. J. George. 2003. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ. Res. 92:1314-1321.
49. Koutsouki, E., C. A. Beeching, S. C. Slater, O. W. Blaschuk, G. B. Sala-Newby, and S. J. George. 2005. N-cadherin-dependent cell-cell contacts promote human saphenous vein smooth muscle cell survival. Arterioscler. Thromb. Vasc. Biol. 25:982-988.
50. Gramley, F., J. Lorenzen, E. Koellensperger, K. Kettering, C. Weiss, and T. Munzel. 2010. Atrial fibrosis and atrial fibrillation: The role of the TGF-beta (1) signaling pathway. Int. J. Cardiol. 143:405-413.
51. Sun, Y., F. J. Ramires, G. Zhou, V. K. Ganjam, and K. T. Weber. 1997. Fibrous tissue and angiotensin II. J. Mol. Cell. Cardiol. 29:2001-2012.
52. O'Kane, S., and M. W. Ferguson. 1997. Transforming growth factor beta s and wound healing. Int. J. Biochem. Cell Biol. 29:63-78.
53. Nahrendorf, M., F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J. L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204:3037-3047.
54. Botta, R., E. Gao, G. Stassi, D. Bonci, E. Pelosi, D. Zwas, M. Patti, L. Colonna, M. Baiocchi, S. Coppola, et al. 2004. Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J. 18:1392-1394.
55. Fazel, S., M. Cimini, L. Chen, S. Li, D. Angoulvant, P. Fedak, S. Verma, R. D. Weisel, A. Keating, and R. K. Li. 2006. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116:1865-1877.
56. Jujo, K., M. Ii, and D. W. Losordo. 2008. Endothelial progenitor cells in neovascularization of infarcted myocardium. J. Mol. Cell. Cardiol. 45:530-544.
57. Shultz, L. D., P. A. Lang, S. W. Christianson, B. Gott, B. Lyons, S. Umeda, E. Leiter, R. Hesselton, E. J. Wagar, J. H. Leif, et al. 2000. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164:2496-2507.
58. van Weel, V., R. E. Toes, L. Seghers, M. M. Deckers, M. R. de Vries, P. H. Eilers, J. Sipkens, A. Schepers, D. Eefting, V. W. van Hinsbergh, et al. 2007. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler. Thromb. Vasc. Biol. 27:2310-2318.
59. Koch, M., K. Savvatis, M. Scheeler, S. Dhayat, K. Bonaventura, T. Pohl, A. Riad, S. Bulfone-Paus, H. P. Schultheiss, and C. Tschöpe. 2010. Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy. Int. Immunopharmacol. 10:207-212.